Recombinant multi-species RNF130 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF130 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene contains a RING finger motif and is similar to g1, a Drosophila zinc-finger protein that is expressed in mesoderm and involved in embryonic development. The expression of the mouse counterpart was found to be upregulated in myeloblastic cells following IL3 deprivation, suggesting that this gene may regulate growth factor withdrawal-induced apoptosis of myeloid precursor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
The Alternative Names of target: 2510042A13Rik,E3 ubiquitin-protein ligase RNF130,G1RP,G1RZFP,G1rp,GOLIATH,GP,Goliath homolog (H-Goliath),RING finger protein 130,RING-type E3 ubiquitin transferase RNF130,RNF130,Rnf130

Target products collectionGo to RNF130 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1505-Ag-1/ GM-Tg-hg-IP1505-Ag-2 Human RNF130 protein Human
GM-Tg-rg-IP1505-Ag-1/ GM-Tg-rg-IP1505-Ag-2 Rat RNF130 protein Rat
GM-Tg-mg-IP1505-Ag-1/ GM-Tg-mg-IP1505-Ag-2 Mouse RNF130 protein Mouse
GM-Tg-cynog-IP1505-Ag-1/ GM-Tg-cynog-IP1505-Ag-2 Cynomolgus/Rhesus macaque RNF130 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1505-Ag-1/ GM-Tg-felg-IP1505-Ag-2 Feline RNF130 protein Feline
GM-Tg-cang-IP1505-Ag-1/ GM-Tg-cang-IP1505-Ag-2 Canine RNF130 protein Canine
GM-Tg-bovg-IP1505-Ag-1/ GM-Tg-bovg-IP1505-Ag-2 Bovine RNF130 protein Bovine
GM-Tg-equg-IP1505-Ag-1/ GM-Tg-equg-IP1505-Ag-2 Equine RNF130 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1505-Ag-1/ GM-Tg-hg-IP1505-Ag-2; GM-Tg-rg-IP1505-Ag-1/ GM-Tg-rg-IP1505-Ag-2;
GM-Tg-mg-IP1505-Ag-1/ GM-Tg-mg-IP1505-Ag-2; GM-Tg-cynog-IP1505-Ag-1/ GM-Tg-cynog-IP1505-Ag-2;
GM-Tg-felg-IP1505-Ag-1/ GM-Tg-felg-IP1505-Ag-2; GM-Tg-cang-IP1505-Ag-1/ GM-Tg-cang-IP1505-Ag-2;
GM-Tg-bovg-IP1505-Ag-1/ GM-Tg-bovg-IP1505-Ag-2; GM-Tg-equg-IP1505-Ag-1/ GM-Tg-equg-IP1505-Ag-2
Products Name RNF130 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNF130
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF130 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.